DrugPatentWatch Database Preview
Mayne Pharma Company Profile
Email this page to a colleague
» See Plans and PricingWhat is the competitive landscape for MAYNE PHARMA, and what generic alternatives to MAYNE PHARMA drugs are available?
MAYNE PHARMA has seventy-two approved drugs.
There are fourteen US patents protecting MAYNE PHARMA drugs. There is one tentative approval on MAYNE PHARMA drugs.
There are seventy-three patent family members on MAYNE PHARMA drugs in twenty-two countries and fifty-five supplementary protection certificates in thirteen countries.
Summary for Mayne Pharma
| International Patents: | 73 |
| US Patents: | 14 |
| Tradenames: | 68 |
| Ingredients: | 51 |
| NDAs: | 72 |
| Patent Litigation for Mayne Pharma: | See patent lawsuits for Mayne Pharma |
Drugs and US Patents for Mayne Pharma
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mayne Pharma | CARBIDOPA AND LEVODOPA | carbidopa; levodopa | TABLET;ORAL | 073618-001 | Aug 28, 1992 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Mayne Pharma Inc | LIOTHYRONINE SODIUM | liothyronine sodium | TABLET;ORAL | 090097-001 | Mar 20, 2009 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Mayne Pharma Inc | HYDROCODONE BITARTRATE AND PSEUDOEPHEDRINE HYDROCHLORIDE | hydrocodone bitartrate; pseudoephedrine hydrochloride | SOLUTION;ORAL | 205658-001 | Nov 17, 2015 | DISCN | No | No | Start Trial | Start Trial | |||||
| Mayne Pharma | TRI-NORINYL 21-DAY | ethinyl estradiol; norethindrone | TABLET;ORAL-21 | 018977-001 | Apr 13, 1984 | DISCN | No | No | Start Trial | Start Trial | |||||
| Mayne Pharma | DORYX MPC | doxycycline hyclate | TABLET, DELAYED RELEASE;ORAL | 050795-007 | May 20, 2016 | DISCN | Yes | No | 6,958,161 | Start Trial | Y | Start Trial | |||
| Mayne Pharma | DORYX MPC | doxycycline hyclate | TABLET, DELAYED RELEASE;ORAL | 050795-007 | May 20, 2016 | DISCN | Yes | No | 8,715,724 | Start Trial | Y | Start Trial | |||
| Mayne Pharma Inc | MORPHINE SULFATE | morphine sulfate | TABLET, EXTENDED RELEASE;ORAL | 205386-002 | Oct 28, 2016 | AB | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Mayne Pharma
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Mayne Pharma | TRI-NORINYL 21-DAY | ethinyl estradiol; norethindrone | TABLET;ORAL-21 | 018977-001 | Apr 13, 1984 | 4,390,531 | Start Trial |
| Mayne Pharma | TRI-NORINYL 28-DAY | ethinyl estradiol; norethindrone | TABLET;ORAL-28 | 018977-002 | Apr 13, 1984 | 4,390,531 | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for MAYNE PHARMA drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Delayed-release Tablets | 60 mg and 120 mg | ➤ Subscribe | 2017-09-28 |
| ➤ Subscribe | Delayed-release Tablets | 150 mg | ➤ Subscribe | 2008-12-19 |
| ➤ Subscribe | Delayed-release Tablets | 200 mg | ➤ Subscribe | 2014-05-19 |
| ➤ Subscribe | Delayed-release Tablets | 50 mg | ➤ Subscribe | 2015-11-05 |
| ➤ Subscribe | Delayed-release Tablets | 200 mg | ➤ Subscribe | 2013-08-12 |
| ➤ Subscribe | Delayed-release Tablets | 80 mg | ➤ Subscribe | 2015-07-01 |
International Patents for Mayne Pharma Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Denmark | 1112062 | Start Trial |
| Australia | 7252900 | Start Trial |
| World Intellectual Property Organization (WIPO) | 2006129161 | Start Trial |
| South Korea | 20200065093 | Start Trial |
| Australia | 6069299 | Start Trial |
| Poland | 1917072 | Start Trial |
| New Zealand | 508259 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Mayne Pharma Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0383579 | C960030 | Netherlands | Start Trial | PRODUCT NAME: REMIFENTANYLUM, DESGEWENST IN DE VORM VAN EEN ZUURADDITIE-ZOUT, IN HET BIJZONDER HET HYDROCHLORIDE; NAT. REGISTRATION NO/DATE: RVG 20601 - RVG 20603 19961015; 36335.00.00, 36335.01.00, 36335.02.00 19960517 |
| 1214076 | 49/2008 | Austria | Start Trial | PRODUCT NAME: WIRKSTOFFKOMBINATION VON ETHINYLESTRADIOL UND DROSPIRENON; REGISTRATION NO/DATE: 1-27586 20080612 |
| 0771217 | CA 2006 00038 | Denmark | Start Trial | PRODUCT NAME: ETHINYLESTRADIOL (SOM BETA-CYCLODEXTRIN-CLATHRAT) OG DROSPIRENON; NAT. REG. NO/DATE: 38687 20060627; FIRST REG. NO/DATE: EU RVG 31781 20050804 |
| 0770388 | SPC/GB09/026 | United Kingdom | Start Trial | PRODUCT NAME: ESTRADIOL AND COMBINATIONS OF ESTRADIOL AND DIENOGEST, PREFERABLY ESTRADIOL VALERATE AND COMBINATIONS OF ESTRADIOL VALERATE AND DIENOGEST; REGISTERED: BE BE 327792 20081103; UK PL 00010/0576-0001 20081208 |
| 1380301 | 2009C/007 | Belgium | Start Trial | PRODUCT NAME: DROSPIRENONE-ETHINYLESTRADIOL; AUTHORISATION NUMBER AND DATE: BE321386 20080811 |
| 0836511 | CA 2006 00019 | Denmark | Start Trial | PRODUCT NAME: FENTANYL HYDROCHLORID |
| 0237929 | 97C0112 | Belgium | Start Trial | PRODUCT NAME: TOLCAPONE; REGISTRATION NO/DATE: EU/1/97/044/001 19970827 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
